When Prevention Fails: Obesity Treatment Strategies

被引:26
作者
Aronne, Louis J. [1 ,2 ]
Wadden, Thomas [3 ,4 ]
Isoldi, Kathy Keenan [5 ]
Woodworth, Kristina A. [6 ]
机构
[1] New York Presbyterian Hosp, Comprehens Weight Control Program, Weill Cornell Med Coll, New York, NY 10028 USA
[2] Weill Cornell Med Coll, Dept Med, New York, NY USA
[3] Univ Penn, Dept Psychol, Sch Med, Philadelphia, PA 19104 USA
[4] Univ Penn, Ctr Weight & Eating Disorders, Philadelphia, PA 19104 USA
[5] New York Presbyterian Hosp, Comprehens Weight Control Program, Clin Nutr Serv, New York, NY 10028 USA
[6] SciMantis Commun Inc, Pen Argyl, PA USA
关键词
Exercise; Diet and lifestyle intervention; Obesity treatment; Pharmacotherapy; Weight loss; LIFE-STYLE MODIFICATION; CANNABINOID-1 RECEPTOR BLOCKER; CARDIOVASCULAR RISK-FACTORS; TERM DIETARY INTERVENTION; LOW-CALORIE DIET; WEIGHT-LOSS; PHARMACOLOGICAL-TREATMENT; OVERWEIGHT PATIENTS; DOUBLE-BLIND; RIMONABANT;
D O I
10.1016/j.amjmed.2009.01.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The obesity epidemic has resulted in increasingly urgent calls for large-scale prevention strategies. Meanwhile, effective treatment approaches that result in sustainable weight loss are needed to attenuate the cardiometabolic risks that may lead to comorbid illnesses and early mortality. Public education efforts geared toward those afflicted with obesity should emphasize that a relatively modest reduction in body weight dramatically reduces disease risk, thereby improving overall long-term health. Setting realistic weight loss goals with patients should reduce the overwhelming frustration often associated with the belief that large amounts of weight loss are needed for improved health. This misconception often impedes overweight and obese individuals from seeking treatment. Effective strategies are available to help overweight and obese individuals achieve reasonable weight loss goals. Important challenges exist in preventing weight regain following weight loss intervention. Studies are underway to identify new therapeutic strategies to effectively reduce weight, as well as to provide long-term data on successful weight loss maintenance strategies. (C) 2009 Published by Elsevier Inc. The American Journal of Medicine (2009) 122, S24-S32
引用
收藏
页码:S24 / S32
页数:9
相关论文
共 50 条
  • [31] Long-term maintenance of weight loss with sibutramine in a GP setting following a specialist guided very-low-calorie diet: a double-blind, placebo-controlled, parallel group study
    Mathus-Vliegen, EMH
    [J]. EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2005, 59 (Suppl 1) : S31 - S38
  • [32] Ness-Abramof Rosane, 2005, Timely Top Med Cardiovasc Dis, V9, pE31
  • [33] Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors - A meta-analysis of randomized controlled trials
    Nordmann, AJ
    Nordmann, A
    Briel, M
    Keller, U
    Yancy, WS
    Brehm, BJ
    Bucher, HC
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (03) : 285 - 293
  • [34] The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: The diabetes prevention program randomized trial
    Orchard, TJ
    Temprosa, M
    Goldberg, R
    Haffner, S
    Ratner, R
    Marcovina, S
    Fowler, S
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 142 (08) : 611 - 619
  • [35] Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients - RIO-North America: A randomized controlled trial
    Pi-Sunyer, F
    Aronne, LJ
    Heshmati, HM
    Devin, J
    Rosenstock, J
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (07): : 761 - 775
  • [36] Effect of calorie restriction with or without exercise on body composition and fat distribution
    Redman, Leanne M.
    Heilbronn, Leonie K.
    Martin, Corby K.
    Alfonso, Anthony
    Smith, Steven R.
    Ravussin, Eric
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (03) : 865 - 872
  • [37] Exenatide elicits sustained glycaemic control and progressive reduction of body weight in patients with type 2 diabetes inadequately controlled by sulphonylureas with or without metformin
    Riddle, Matthew C.
    Henry, Robert R.
    Poon, Terri H.
    Zhang, Bei
    Mac, Susanna M.
    Holcombe, John H.
    Kim, Dennis D.
    Maggs, David G.
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2006, 22 (06) : 483 - 491
  • [38] SCHEEN AJ, 2005, 65 ANN SCI SESS AM D
  • [39] Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study
    Scheen, Andre J.
    Finer, Nick
    Hollander, Priscilla
    Jensen, Michael D.
    Van Gaal, Luc F.
    [J]. LANCET, 2006, 368 (9548) : 1660 - 1672
  • [40] Optimal treatment of obesity-related hypertension - The Hypertension-Obesity-Sibutramine (HOS) Study
    Scholze, Juergen
    Grimm, Elmar
    Herrmann, Dana
    Unger, Thomas
    Kintscher, Ulrich
    [J]. CIRCULATION, 2007, 115 (15) : 1991 - 1998